"Texas Oncology is an independent private practice with more than 500 physicians and 210 locations across the state. Meeting the oncology needs of Texans for more than 35 years, the practice includes Texas Center for Proton Therapy, Texas Breast Specialists, Texas Oncology Surgical Specialists, and Texas Center for Interventional Surgery. As a lead participant in US Oncology Research, Texas Oncology played a role in the development of more than 100 FDA-approved therapies."

During the past decade, Texas Oncology - Southwest Fort Worth conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 8 clinical trials were completed, i.e. on average, 400% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Texas Oncology - Southwest Fort Worth" #1 sponsor was "Radiation Therapy Oncology Group" with 5 trials, followed by "Pfizer" with 2 trials sponsored, "Dendreon" with 1 trials sponsored, "GRAIL, LLC" with 1 trials sponsored and "Hoffmann-La Roche" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Texas Oncology - Southwest Fort Worth" #1 collaborator was "NRG Oncology" with 5 trials as a collaborator, "National Cancer Institute (NCI)" with 5 trials as a collaborator and "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Texas Oncology - Southwest Fort Worth" are "Metastatic Breast Cancer" (2 trials), "Prostate Cancer" (2 trials), "Advanced Breast Cancer" (1 trials), "Advanced Prostate Cancer" (1 trials) and "Anal Cancer" (1 trials). Many other conditions were trialed in "Texas Oncology - Southwest Fort Worth" in a lesser frequency.

Most popular intervention types in "Texas Oncology - Southwest Fort Worth" are "Drug" (7 trials), "Radiation" (5 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "100mg/m2 adjuvant temozolomide days 1 to 5 of 28 day cycle" (1 trials), "75mg/m2 adjuvant temozolomide days 1-21 of 28 day cycle" (1 trials), "Axitinib (AG-013736)" (1 trials) and "Bevacizumab [Avastin]" (1 trials). Other intervention names were less common.

The vast majority of trials in "Texas Oncology - Southwest Fort Worth" are 8 trials for "All" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Texas Oncology - Southwest Fort Worth". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Texas Oncology - Southwest Fort Worth, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Texas Oncology - Southwest Fort Worth, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".